Whitepaper: The Relevance of Polymorph Screening in the Pharmaceutical Industry

[Article Title]

Solid form screening, the activity of discovering and characterizing different solid forms of an active pharmaceutical ingredient (API), is an essential part of drug development. This screening process needs to be designed, performed, and evaluated carefully, since the decisions made based on the screening may have consequences on the whole lifecycle of a pharmaceutical product.

This paper discusses some basic principles about solid form screening and how we implement them at Eurofins CDMO Alphora to help our clients with this important task.

Download the Document

    * denotes a required field

    Please fill out the information below. If you are already registered, and this information will be filled out for you.

  • Please enter your first and last name.

  • Please enter the name of the company or institution you work at.

  • Please enter your mailing address.

  • Please enter the e-mail address you would like to be contacted at.

  • Please enter the phone number you would like to be contacted at.

    • By submitting this form, you consent to American Pharmaceutical Review storing your email address and contact information and transmitting your contact information to the content sponsor. You may request to be removed at any time.